JOVANA
Library Glossary Getting Started Three Levels Fields How it works Mission
Join the mission
All guides

Covalent Inhibitors & Antibody–Drug Conjugates

Two ways to sharpen the attack: forge a permanent chemical bond to the target, or strap a cytotoxic warhead to an antibody that delivers it only to the tumour.

Covalent inhibitors: a permanent grip

Most drugs bind their target reversibly — they hold on for a while, then let go, in a constant dance on and off. A covalent inhibitor is different: it forms an actual chemical bond to the protein, latching on permanently. The drug carries a mildly reactive group, the warhead, positioned to reach a specific amino acid — usually a cysteine — sitting in or beside the target's pocket. Once docked, the warhead snaps shut, and the inhibitor is welded in place for the life of that protein.

The payoff is an effectively infinite residence time: the target stays blocked until the cell builds a brand-new copy of the protein. That gives deep, durable inhibition at low doses. The danger is obvious — a reactive warhead could also bond to the *wrong* protein, giving off-target covalent binding and toxicity. The craft is to make the warhead only mild, so it reacts fast *once the drug is already sitting in the right pocket*, and barely at all when floating free.

Antibody–drug conjugates: a guided missile

An antibody–drug conjugate (ADC) solves the selectivity problem from a completely different angle. Instead of making the *poison* smart, it makes the *delivery* smart. An ADC has three parts bolted together: a monoclonal antibody that recognises a protein on the cancer cell's surface, a hugely potent cytotoxic payload — a poison far too toxic to ever give on its own — and a chemical linker tying the two together.

  1. The antibody circulates and docks onto its target protein, which is far more abundant on the tumour cell than on healthy tissue. This is the homing step — the source of the selectivity.
  2. The whole conjugate is swallowed into the cancer cell, pulled inside in a membrane bubble.
  3. Inside, the linker is cut — by an acidic environment or an enzyme — releasing the payload only now that it is safely *inside the right cell*.
  4. The freed poison shatters the cell from within, triggering apoptosis — while neighbouring healthy cells, lacking the surface target, are never opened in the first place.